Details for New Drug Application (NDA): 073516
✉ Email this page to a colleague
NDA 073516 describes KETOPROFEN, which is a drug marketed by Actavis Labs Fl Inc, Alkermes Gainesville, Mylan, Misemer, Rising, Teva, and Perrigo, and is included in ten NDAs. It is available from five suppliers. Additional details are available on the KETOPROFEN profile page.
The generic ingredient in KETOPROFEN is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
The generic ingredient in KETOPROFEN is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
Summary for 073516
| Tradename: | KETOPROFEN |
| Applicant: | Teva |
| Ingredient: | ketoprofen |
| Patents: | 0 |
Pharmacology for NDA: 073516
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 073516
Suppliers and Packaging for NDA: 073516
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| KETOPROFEN | ketoprofen | CAPSULE;ORAL | 073516 | ANDA | Medsource Pharmaceuticals | 45865-485 | 45865-485-30 | 30 CAPSULE in 1 BOTTLE (45865-485-30) |
| KETOPROFEN | ketoprofen | CAPSULE;ORAL | 073516 | ANDA | Medsource Pharmaceuticals | 45865-485 | 45865-485-51 | 120 CAPSULE in 1 BOTTLE (45865-485-51) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Dec 22, 1992 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
